UF Health: Timing, Consistency of Activity Linked to Better Fitness
A new UF study, funded by the NIA, shows that the timing and consistency of daily activity may be associated with improved cardiorespiratory fitness and walking efficiency — two key indicators of healthy aging
Water Researchers Develop Prediction System for Harmful Algae
UF researchers have developed a next-day prediction model for harmful algal blooms, providing water managers with timely tools to mitigate environmental and public health risks.
Will Genome Modifications Define Next-Gen AAV Vectors?
UF researcher Arun Srivastava, Ph.D., a gene therapy pioneer, shares his expert perspective on genome-modified AAV vectors, offering insights into how next-generation viral therapies may be shaped by precision genetic engineering.
Atsena Therapeutics Announces Positive Clinical Data From Part A of Phase I/II Trial Evaluating ATSN-201 Gene Therapy To Treat X-Linked Retinoschisis (XLRS)
UF startup Atsena Therapeutics announced positive clinical data results from Part A of the LIGHTHOUSE study, a Phase I/II clinical trial evaluating subretinal injection of ATSN-201 for the treatment of X-linked retinoschisis (XLRS).
XPRIZE UF
UF Innovate | The Hub resident client FNN, in collaboration with UF researchers, advances to the semi-finals of the XPRIZE Wildfire competition with its AI-driven technology aimed at early detection and suppression of wildfires.
Dalir Joins National Effort To Enable 3D Optical Packaging for Next-Gen AI Chips
UF researcher Hamed Dalir, Ph.D., is collaborating on a $5.2 million federally funded project to develop a transformative 3D optical packaging platform that enables scalable, high-bandwidth, energy-efficient chip-to-chip optical communication.
UF Audio Deepfakes Study Could Ultimately Help Hearing-Impaired Detect Fraud
UF researchers found that cochlear implant users are more vulnerable to audio deepfakes, highlighting the need for better detection systems to protect the hearing-impaired from potential fraud.
UF Innovate Awarded Top Entrepreneurship Honors at International Conference
The University of Florida’s start-up incubator, UF Innovate, further solidified its Accelerator program as among the industry’s best after earning top awards at the 2025 International Business Innovation Association’s annual conference in Philadelphia.
Pheronym®’s Nemastim™ Advances Biological Control of Whiteflies in Breakthrough Foliar Application
UF Innovate | Accelerate alum Pheronym®, an ag-biotech company in sustainable pest management, has announced that pheromones increased beneficial nematodes’ performance against whiteflies in a foliar application.
Oragenics, Inc. Announces Approval To Initiate Phase II Concussion Drug Trial in Australia
UF Innovate | Accelerate graduate Oragenics announced that it has received approval from the Human Research Ethics Committee (HREC) in Australia to initiate a Phase II clinical trial evaluating ONP-002 for the treatment of mild traumatic brain injury (mTBI).